Atlanta-based biotechnology company Florence Healthcare has secured $7.1 million in Series B funding, according to company database Crunchbase, topping the city’s recent funding headlines. The cash infusion was announced Oct. 10 and led by Fulcrum Equity Partners.
According to its Crunchbase profile, "Florence advances clinical research through software. The Florence eBinder Suite replaces paper investigator site files, trial master files and source binders with a shared platform. This shared platform approach makes remote monitoring of eRegulatory and eSource documents possible while giving sponsors real-time insights into study progress."
The five-year-old company also raised a $1.7 million seed round in 2016.
Over the past year, four Atlanta-based biotechnology companies have secured venture funding, totaling $34 million in new investment to the local industry.
In other local funding news, B2B company Reibus International announced a $3.2 million seed funding round on Oct. 23, led by Bowery Capital.
According to Crunchbase, "We are an online B2B marketplace for prime and excess materials used in industrial markets. For sellers, our platform is designed to maximize price performance, minimize time to market, expand market reach and reduce sales and marketing-related expenses as compared to traditional methods. For buyers, our marketplace increases selection and market transparency, while reducing the time and investment required to search for, identify, evaluate and procure materials."
The company also raised a $600,000 pre-seed round earlier this year.